Biocorrx Inc. (BICX) SEC Filing 8-K Material Event for the period ending Friday, March 1, 2019

Biocorrx Inc.

CIK: 1443863 Ticker: BICX

View differences made from one to another to evaluate Biocorrx Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biocorrx Inc..


Assess how Biocorrx Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biocorrx Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Biocorrx Inc. provided additional information to their SEC Filing as exhibits

Ticker: BICX
CIK: 1443863
Form Type: 8-K Corporate News
Accession Number: 0001477932-19-000875
Submitted to the SEC: Thu Mar 07 2019 4:45:38 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Friday, March 1, 2019
Industry: Specialty Outpatient Facilities
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: